Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
ENTITY
Celltrion Inc (068270 KS)
Watchlist
462
Analysis
Health Care
•
South Korea
Celltrion Inc. produces and sells biosimilar products and also provides consignm ent processing service for other companies. The Company's main product is Abata cept which is for arthritis treatment
more
Watchlist
Filings
Presentations
Events
Refresh
Exchange Announcement •
02 Jul 2024 16:33
Material Business Matters Related to Investment Decisions(Adoption of positive opinion for CT-P43 Stelara biosimilar by Committee for Medicinal Products for Human Use CHMP, European Medicines Agency EMA)
Attachment
Exchange Announcement •
02 Jul 2024 16:32
Material Business Matters Related to Investment Decisions(IND submission for CT-P55 Consentyx biosimilar to the FDA)
Attachment
Exchange Announcement •
25 Jun 2024 16:33
Material Business Matters Related to Investment Decisions(MFDS approval of BLA for Omlyclo CT-P39, Xolair biosimilar)
Attachment
Exchange Announcement •
20 Jun 2024 15:40
Material Business Matters Related to Investment Decisions(IND submission for CT-P13 SC Zymfentra on rheumatoid arthritis patients to the FDA)
Attachment
Exchange Announcement •
18 Jun 2024 16:39
Material Business Matters Related to Investment Decisions(EMA approval of IND for CT-P13 SC subcutaneous formulation of Remsima on Crohns disease patients Part 1)
Attachment
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.33.7
x